Company intelligence / Profile preview

Scimitar Equity Research

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Scimitar Equity Research is a boutique investment research firm specializing in the life sciences, biotechnology, and healthcare sectors. The firm provides detailed equity analysis, valuation models, and strategic insights for institutional investors and corporate clients focusing on small- and mid-cap companies. Led by experienced analysts, Scimitar identifies emerging trends and undervalued opportunities within the complex drug development and medical technology landscapes. Their services include company-specific reports, industry overviews, and advisory services tailored to the needs of the healthcare investment community.

Industry: Consulting

Beyond the preview

Go deeper on Scimitar Equity Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scimitar Equity Research.

Explore the full profile